Derfor anbefales brugen af doxazosin- tabletter med forlænget afgivelse ikke (se afsnit 4. 4).
8/ 24 patients with severe hepatic impairment clinical experience is lacking and therefore the use of doxazosin prolonged release tablets is not recommended (see section 4.4).